JP Morgan Chase’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.09B | Sell |
10,428,170
-13,722,329
| -57% | -$1.66B | 0.06% | 256 |
|
|
2026
Q1 | $3.7B | Buy |
24,150,499
+950,987
| +4% | +$146M | 0.24% | 91 |
|
|
2025
Q4 | $4.04B | Buy |
23,199,512
+151,836
| +0.7% | +$27.7M | 0.25% | 87 |
|
|
2025
Q3 | $3.32B | Buy |
23,047,676
+7,411,277
| +47% | +$908M | 0.2% | 106 |
|
|
2025
Q2 | $1.57B | Buy |
15,636,399
+9,282,377
| +146% | +$710M | 0.1% | 190 |
|
|
2025
Q1 | $485M | Buy |
6,354,022
+3,067,774
| +93% | +$235M | 0.04% | 390 |
|
|
2024
Q4 | $227M | Sell |
3,286,248
-20,098
| -0.6% | -$1.45M | 0.02% | 620 |
|
|
2024
Q3 | $241M | Buy |
3,306,346
+380,161
| +13% | +$28.1M | 0.02% | 618 |
|
|
2024
Q2 | $196M | Buy |
2,926,185
+2,636,654
| +911% | +$102M | 0.02% | 662 |
|
|
2024
Q1 | $7.85M | Sell |
289,531
-92,963
| -24% | -$2.6M | ﹤0.01% | 2707 |
|
|
2023
Q4 | $11.9M | Sell |
382,494
-25,471
| -6% | -$660K | ﹤0.01% | 2304 |
|
|
2023
Q3 | $10.3M | Buy |
407,965
+46,907
| +13% | +$1.07M | ﹤0.01% | 2217 |
|
|
2023
Q2 | $7.62M | Buy |
361,058
+68,169
| +23% | +$1.29M | ﹤0.01% | 2528 |
|
|
2023
Q1 | $5M | Sell |
292,889
-97,110
| -25% | -$1.89M | ﹤0.01% | 2819 |
|
|
2022
Q4 | $7.79M | Buy |
389,999
+131,475
| +51% | +$2.54M | ﹤0.01% | 2468 |
|
|
2022
Q3 | $5.57M | Sell |
258,524
-107,720
| -29% | -$2.58M | ﹤0.01% | 2655 |
|
|
2022
Q2 | $7.22M | Buy |
366,244
+254,542
| +228% | +$5.33M | ﹤0.01% | 2435 |
|
|
2022
Q1 | $2.63M | Buy |
111,702
+15,774
| +16% | +$367K | ﹤0.01% | 3540 |
|
|
2021
Q4 | $2.61M | Sell |
95,928
-101,761
| -51% | -$2.91M | ﹤0.01% | 3642 |
|
|
2021
Q3 | $5.44M | Sell |
197,689
-6,740
| -3% | -$177K | ﹤0.01% | 2965 |
|
|
2021
Q2 | $5.82M | Buy |
204,429
+30,216
| +17% | +$897K | ﹤0.01% | 2933 |
|
|
2021
Q1 | $5.93M | Buy |
174,213
+2,080
| +1% | +$79.5K | ﹤0.01% | 2820 |
|
|
2020
Q4 | $5.73M | Sell |
172,133
-2,057
| -1% | -$75.1K | ﹤0.01% | 2693 |
|
|
2020
Q3 | $5.71M | Sell |
174,190
-8,787
| -5% | -$253K | ﹤0.01% | 2458 |
|
|
2020
Q2 | $5.04M | Sell |
182,977
-12,234
| -6% | -$290K | ﹤0.01% | 2449 |
|
|
2020
Q1 | $3.13M | Sell |
195,211
-149,586
| -43% | -$3.55M | ﹤0.01% | 2629 |
|
|
2019
Q4 | $8.23M | Buy |
344,797
+103,467
| +43% | +$2.1M | ﹤0.01% | 2281 |
|
|
2019
Q3 | $4.26M | Sell |
241,330
-220,617
| -48% | -$4.26M | ﹤0.01% | 2830 |
|
|
2019
Q2 | $11.7M | Buy |
461,947
+238,635
| +107% | +$6.65M | ﹤0.01% | 1970 |
|
|
2019
Q1 | $6.49M | Buy |
223,312
+73
| +0% | +$1.89K | ﹤0.01% | 2381 |
|
|
2018
Q4 | $2.93M | Sell |
223,239
-283,152
| -56% | -$4.52M | ﹤0.01% | 2991 |
|
|
2018
Q3 | $10.2M | Buy |
506,391
+241,921
| +91% | +$5.46M | ﹤0.01% | 2188 |
|
|
2018
Q2 | $6.25M | Buy |
264,470
+45,676
| +21% | +$1.18M | ﹤0.01% | 2511 |
|
|
2018
Q1 | $4.93M | Buy |
218,794
+11,604
| +6% | +$305K | ﹤0.01% | 2585 |
|
|
2017
Q4 | $6.46M | Sell |
207,190
-243,211
| -54% | -$7.18M | ﹤0.01% | 2465 |
|
|
2017
Q3 | $13.8M | Sell |
450,401
-547,777
| -55% | -$10.4M | ﹤0.01% | 1751 |
|
|
2017
Q2 | $17.1M | Sell |
998,178
-470,989
| -32% | -$8.04M | ﹤0.01% | 1564 |
|
|
2017
Q1 | $25.7M | Sell |
1,469,167
-95,990
| -6% | -$1.48M | 0.01% | 1305 |
|
|
2016
Q4 | $20.7M | Sell |
1,565,157
-33,478
| -2% | -$457K | 0.01% | 1445 |
|
|
2016
Q3 | $23.2M | Sell |
1,598,635
-375,626
| -19% | -$4.7M | 0.01% | 1278 |
|
|
2016
Q2 | $19.5M | Sell |
1,974,261
-110,246
| -5% | -$1.29M | ﹤0.01% | 1417 |
|
|
2016
Q1 | $26.4M | Sell |
2,084,507
-99,265
| -5% | -$1.3M | 0.01% | 1157 |
|
|
2015
Q4 | $39.6M | Buy |
2,183,772
+85,800
| +4% | +$1.51M | 0.01% | 927 |
|
|
2015
Q3 | $39M | Sell |
2,097,972
-17,398
| -0.8% | -$434K | 0.01% | 902 |
|
|
2015
Q2 | $51.7M | Buy |
2,115,370
+49,581
| +2% | +$1.13M | 0.01% | 866 |
|
|
2015
Q1 | $43M | Buy |
2,065,789
+161,050
| +8% | +$2.84M | 0.01% | 966 |
|
|
2014
Q4 | $29.5M | Buy |
1,904,739
+211,928
| +13% | +$3.01M | 0.01% | 1236 |
|
|
2014
Q3 | $22.1M | Buy |
1,692,811
+385,846
| +30% | +$5.82M | 0.01% | 1385 |
|
|
2014
Q2 | $26.1M | Buy |
1,306,965
+371,164
| +40% | +$5.5M | 0.01% | 1182 |
|
|
2014
Q1 | $17.8M | Sell |
935,801
-379,038
| -29% | -$7.2M | ﹤0.01% | 1390 |
|
|
2013
Q4 | $22.4M | Sell |
1,314,839
-253,479
| -16% | -$3.88M | 0.01% | 1256 |
|
|
2013
Q3 | $24.5M | Buy |
1,568,318
+1,234,394
| +370% | +$15.7M | 0.01% | 1199 |
|
|
2013
Q2 | $3.99M | Buy |
+333,924
| New | +$3.41M | ﹤0.01% | 2288 |
|
Other funds holding INSM
JP Morgan Chase's INSM Position: Q2 2026 in Review
JP Morgan Chase reduced its Insmed (INSM) stake by 57% in Q2 2026, selling an estimated $1.66B and leaving 10,428,170 shares worth $1.09B. The position accounts for 0.06% of the portfolio, ranked #256.
JP Morgan Chase first reported a position in INSM in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.04B in Q4 2025. 382 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- JP Morgan Chase held 10,428,170 shares of Insmed worth $1.09B as of Q2 2026.
- JP Morgan Chase sold 13,722,329 Insmed shares in Q2 2026, an estimated $1.66B.
- Insmed made up 0.06% of JP Morgan Chase's portfolio in Q2 2026, its #256 holding.
- JP Morgan Chase first reported a position in Insmed in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Insmed position peaked at $4.04B in Q4 2025.
- 382 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.